Definitive Contract 75A50124C00017
Award Date 4/29/24
Potential Completion Date 2/27/26
Potential Value $749K
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not listed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Astoria, NY 11101, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $627,627.92 definitive contract to Nature's Toolbox Inc., doing business as Biotechnology, a subsidiary of Nature's Toolbox, Inc., for research and development of a novel, rapidly deployable RNA vaccine production platform under AOI #21 Vaccines on Demand. The firm fixed price contract will be performed in Mexico over a period of approximately two years, from April 2023 through...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1.5 million firm fixed price definitive contract to HDT Bio Corp. to develop an adaptable RNA-based antibody platform for protection against contemporary and emerging human enteroviruses. The three year contract will support HDT Bio Corp.'s work through June 2025 to create a platform that utilizes RNA-based antibodies to provide protection against various...
- This federal contract award to Research And Diagnostic Systems, Inc. (R&D Systems), a subsidiary of Bio-Techne Corporation, was made by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services (HHS). The $10,242.30 firm fixed-price purchase order is for the delivery of antibodies and proteins to support biomedical research, including studies related to COVID-19 and other infectious diseases. R&D Systems is a...
- Regeneron Pharmaceuticals Inc. received a $10.76 million cost-plus-fixed-fee definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) on August 9, 2016, for the development of anti-MERS antibody therapeutics. The contract, which was completed on September 30, 2022, supported work performed at Regeneron's facility in Sleepy Hollow, New York. No set-aside designation was applied to this award. ASPR, a component of the Department of Health and...
- This is a prime contract award to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services. The $14,898,362.53 cost-plus-fixed-fee contract is for biomedical research and development. It has a period of performance through December 31, 2011 and does not have a set-aside designation. Resilience Government Services is a technology-focused...
- This federal contract award to Inbios International Inc., a minority-owned business based in Seattle, Washington, was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). The $749,998 firm fixed-price contract supports research and development (R&D) of an antibody diagnostic for COVID-19. The contract was issued under a Broad Agency Announcement (BAA) solicitation from ASPR's Division of...
- This is a $299,959 SBIR Phase I contract awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to HDT Bio Corp, a biopharmaceutical company that develops drugs and vaccines for cancer, infectious diseases, and other unmet medical needs. The contract is for research, development, testing, and manufacturing services related to HDT Bio Corp's RNA technologies, adjuvants, antibodies, nanoparticles, and other platforms to create new medical...
- This is a $65,867,803.99 definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) to VIR Biotechnology, Inc., a self-certified small disadvantaged business. The contract is for the development of pre-exposure prophylactic monoclonal antibodies for the prevention of influenza illness and medical countermeasures for other emerging pathogens with pandemic potential. This contract was awarded under a Broad...
- This is a $11,295.00 firm fixed price purchase order awarded to Research And Diagnostic Systems, Inc. (R&D Systems) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The contract is for the provision of recombinant human proteins and antibodies, which are essential research reagents used in studies of infectious diseases, cancer, and other health conditions. R&D Systems is a subsidiary of the parent...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded a $23,380.00 firm fixed price purchase order to Research And Diagnostic Systems, Inc. (R&D Systems), a small business manufacturer of research reagents and instruments. The contract is for the delivery of recombinant proteins, which are likely to support NIAID's biomedical research and investigation efforts, including potential COVID-19-related...